Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Frozen Shoulder

Zagazig University

Status: Completed

Conditions: Pain, Shoulder

Treatments: Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine

Study type: Interventional

Funder types: Other

Identifiers

NCT05037994

6909

Details and patient eligibility

About

The patients will be randomly allocated into two equal groups (each 20 patients) using sealed opaque numbered envelopes:

Control Group (C Group) : Patients receive continuous US suprascapular nerve block only.

Gabapentin Group (G Group) : Patients receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.

Both groups compared as regard:

Visual Analogue Scale Range of passive and active movements Patients satisfaction complication related to block The total dose of diclofenac sodium

Enrollment: 40 patients

Sex: All

Ages: 21 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Body mass index ≥ 18 Kg/m2 ≤ 30Kg/m2
• ASA I, II or III.
• Cooperative patients.

Exclusion criteria

• local infection at site of injection.
• coagulopathy
• previous history of mental disorders or chronic drug abuse (opioids, tranquilizers)
• known hypersensitivity to any of the drugs used in the study.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

40 participants in 2 patient groups, including a placebo group

Control Group (C Group)

Placebo Comparator group

Description:

Patients will receive continuous US suprascapular nerve block only.

Treatment:

Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine

Gabapentin Group (G Group)

Experimental group

Description:

Patients will receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.

Treatment:

Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine